GL1X · GenesisL1 explorer

MolNFT v1 · #161516 · protein

Hif prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with a SPIRO[4.5]DECANONE inhibitor (jphm-2-167)

6QGV · Egl nine homolog 1: “Hif prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with a SPIRO[4.5]DECANONE inhibitor (jphm-2-167)”. X-ray diffraction, 3 ligands (J2H, MN, SO4), 1 pocket (best druggability 0.63). MolNFT v1 #161516 on…

PDB
6QGV
Type
protein
Length
198 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Egl nine homolog 1
EC
1.14.11.29
UniProt
Q9GZT9
Ligands
J2H, MN, SO4
Pockets
1 · best druggability 0.63

Structure

x-ray diffraction · 1 distinct chain · 28% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEgl nine homolog 1 (EC 1.14.11.29)protein19828% helix, 30% strandQ9GZT9

Ligands and binding sites

  • J2H · 8-[(3-methylpyridin-2-yl)methyl]-3-(4-phenylphenyl)-1-pyrimidin-2-yl-1,3,8-triazaspiro[4.5]decane-2,4-dione · ligand · chains A
  • MN · Manganese (II) ion · metal · chains A
  • SO4 · Sulfate ion · ion · 2 copies · chains A
  • GOL · Glycerol · additive · chains A
  • IPA · Isopropyl alcohol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11450.630.8631MN, J2H

Compared structures

  • 6QGV · HIF prolyl hydroxylase 2 (PHD2/ EGLN1) in complex with a Spiro[4.5]deca inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9GZT9 · AlphaFold monomer V2.0 prediction for egl nine homolog 1 (Q9GZT9) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.